Zobrazeno 1 - 10
of 162
pro vyhledávání: '"Remy, Dulery"'
Autor:
Iman Abou Dalle, Remy Dulery, Nour Moukalled, Laure Ricard, Nicolas Stocker, Jean El-Cheikh, Mohamad Mohty, Ali Bazarbachi
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Bispecific antibodies (BsAbs) are a new group of targeted therapies that are revolutionizing the treatment landscape of B-cell non-Hodgkin’s lymphoma (B-NHL). In the relapsed/refractory setting, salvage chemotherapy and autologous stem cel
Externí odkaz:
https://doaj.org/article/59c6a495ec6f48fba563a4576b058f13
Autor:
Margot Denier, Sarah Tick, Romain Dubois, Remy Dulery, Andrew W. Eller, Felipe Suarez, Barbara Burroni, Claude-Alain Maurage, Claire Bories, Johanna Konopacki, Michel Puech, Didier Bouscary, Alberte Cantalloube, Emmanuel Héron, Ambroise Marçais, Christophe Habas, Vincent Theillac, Chafik Keilani, Gabrielle R. Bonhomme, Denise S. Gallagher, Julien Boumendil, Wajed Abarah, Neila Sedira, Stéphane Bertin, Sylvain Choquet, José-Alain Sahel, Lilia Merabet, Françoise Brignole-Baudouin, Marc Putterman, Marie-Hélène Errera
Publikováno v:
Medicina, Vol 58, Iss 3, p 456 (2022)
Background and Objectives: Secondary ocular localizations of hematological malignancies are blinding conditions with a poor prognosis, and often result in a delay in the diagnosis. Materials and Methods: We describe a series of rare cases of ocular i
Externí odkaz:
https://doaj.org/article/0a2041018a964f0290f780f152828705
Autor:
Giorgia Battipaglia, Florent Malard, Marie Therèse Rubio, Annalisa Ruggeri, Anne Claire Mamez, Eolia Brissot, Federica Giannotti, Remy Dulery, Anne Christine Joly, Minh Tam Baylatry, Marie Jeanne Kossmann, Jacques Tankovic, Laurent Beaugerie, Harry Sokol, Mohamad Mohty
Publikováno v:
Haematologica, Vol 104, Iss 8 (2019)
Fecal microbiota transplantation is an effective treatment in recurrent Clostridium difficile infection. Promising results to eradicate multidrug-resistant bacteria have also been reported with this procedure, but there are safety concerns in immunoc
Externí odkaz:
https://doaj.org/article/82a6dcf1e602408ebef09a7380d191ee
Autor:
Alexis Genthon, Diana Dragoi, Mara Memoli, Pierre Hirsch, Fabrizia Favale, Ludovic Suner, Michael Chaquin, Pierre Boncoeur, Zora Marjanovic, Agnès Bonnin, Simona Sestili, Remy Dulery, Florent Malard, Eolia Brissot, Anne Banet, Zoe van de Wyngaert, Anne Vekhoff, Francois Delhommeau, Mohamad Mohty, Ollivier Legrand
Publikováno v:
British Journal of Haematology. 198:780-784
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96f739abf22c262437e49fa64d11ffcc
https://doi.org/10.1111/bjh.18290
https://doi.org/10.1111/bjh.18290
Autor:
Jean El Cheikh, Ghassan Bidaoui, Ali Atoui, Khodr Terro, Layal Sharrouf, Ammar Zahreddine, Nour Moukalled, Imane Abou Dalle, Ali Bazarbachi, Mohamad Mohty, Remy Dulery
Publikováno v:
Bone Marrow Transplantation.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d6c42f8f9729a3a97a569b6a39d5658c
https://doi.org/10.1038/s41409-023-01947-z
https://doi.org/10.1038/s41409-023-01947-z
Autor:
Tamim Alsuliman, Jean-Baptiste Mear, Aurélie Trevet, Ibrahim Yakoub-Agha, Pascale Schneider, Laurianne Drieu La Rochelle, Arnaud Campidelli, Amandine Fayard, Remy Dulery, Anne-Claire Mamez, Céline Vicente
Publikováno v:
Bulletin du Cancer. 108:S65-S71
Chimeric antigen receptor (CAR) T cells are a new class of anti-cancer therapy that involves manipulating autologous or allogeneic T cells to express a CAR directed against a membrane antigen. In Europe, tisagenlecleucel (Kymriah™) has marketing au
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6da1451b2fda51c49478b97f5b23aa4f
https://doi.org/10.1016/j.bulcan.2020.11.015
https://doi.org/10.1016/j.bulcan.2020.11.015
Autor:
Jean El Cheikh, ghassan bidaoui, Ali Atoui, khodr terro, layal sharrouf, Ammar Zahreddine, nour moukalled, imane abudalle, Ali Bazarbachi, Mohamad Mohty, Remy Dulery
Background: Clofarabine (Clo) is an immunosuppressive purine analog that may have better anti-leukemic activity than fludarabine (Flu) in the conditioning regimen for allogeneic stem cell transplant (allo-SCT) for acute leukemia patients. The additio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e2d4bcaac90af90a7f1ed5aa4d2fee0a
https://doi.org/10.21203/rs.3.rs-2271254/v1
https://doi.org/10.21203/rs.3.rs-2271254/v1
Autor:
Hedi Bensaber, Emmanuel Bachy, David Beauvais, Remy Dulery, Thomas Gastinne, Bruno Villemagne, Louise Roulin, Etienne Paubelle, Cristina Castilla-Llorente, Thomas Longval, Elodie Gat, Amandine Fayard, Jacques-Olivier Bay, Steven Le Gouill, Roch Houot, Romain Guieze
Publikováno v:
Blood
Blood, 2022, 140 (Supplement 1), pp.3803-3804. ⟨10.1182/blood-2022-158807⟩
Blood, 2022, 140 (Supplement 1), pp.3803-3804. ⟨10.1182/blood-2022-158807⟩
International audience; Background Richter syndrome (RS) refers to the onset of aggressive lymphoma, mostly diffuse large B-cell lymphoma (DLBCL), in patients with chronic lymphocytic leukemia (CLL). The outcome of RS patients is usually very poor wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bd16060b735457c9f309838eb1193eb
https://hal-u-picardie.archives-ouvertes.fr/hal-04020852
https://hal-u-picardie.archives-ouvertes.fr/hal-04020852
Autor:
Geoffroy Hariri, Florent Malard, Hafid Ait-Oufella, Bertrand Guidet, Eric Maury, Jean-Luc Baudel, Remy Dulery, Naïke Bigé, Jean-Rémi Lavillegrand, Guillaume Dumas, Viviane Gournay, Eolia Brissot, Ollivier Legrand, Tomas Urbina, Mohamad Mohty
Publikováno v:
Annals of Hematology. 100:2787-2797
Haploidentical transplantation has extended the availability of allogeneic hematopoietic stem cell transplant (alloHCT) to almost all patients. Sequential conditioning regimens have been proposed for the treatment of hematological active disease. Whe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::008a89fe7066e05263b988de2c033d2c
https://doi.org/10.1007/s00277-021-04640-7
https://doi.org/10.1007/s00277-021-04640-7
Autor:
Mohamad Mohty, Nabaz Jaff, Laurent Garderet, Zora Marjanovic, Elise Corre, Paul Coppo, Simona Lapusan, Marie-Paule Lemonnier, Remy Dulery, Tony Huynh
Publikováno v:
Leukemia & Lymphoma. 62:2235-2241
In multiple myeloma, atypical forms with extramedullary involvement exhibit poor survival. The poly-chemotherapeutic regimen D(T)-PACE has shown high activity in relapsed or refractory multiple myeloma. In this large monocentric retrospective study,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77198c040a3947eff0e148855b55fb31
https://doi.org/10.1080/10428194.2021.1907373
https://doi.org/10.1080/10428194.2021.1907373